
A 22-year-old woman suffering from Xeroderma Pigmentosum (XP), a rare inherited genetic disorder characterized by extreme sensitivity to ultraviolet radiation, is issuing an urgent appeal for international medical aid as aggressive skin cancers threaten her vision and life.
Doctors at Slemani’s Hiwa Hospital warned Avin Hassan Omar that Iraq's harsh climate and daily sunlight exposure are rapidly accelerating her condition, making specialized treatment outside the country her only viable chance of survival.
Key Statements and Focus Area
Xeroderma Pigmentosum (XP) is a severe autosomal recessive disorder caused by mutations in genes responsible for nucleotide excision repair (NER), preventing the body from repairing DNA damage caused by ultraviolet (UV) light. Patients with XP are thousands of times more susceptible to developing skin malignancies, including basal cell carcinomas, squamous cell carcinomas, and melanomas. For Omar, chronic UV exposure from simple outdoor daily tasks has severely damaged her facial skin barrier and ocular tissues, resulting in recurrent tumors that now threaten her recently transplanted cornea.
Because individuals with XP lack fundamental biological defenses against UV radiation, clinicians at Hiwa Hospital stress that effective management requires continuous photoprotection, surgical excisions, and relocation to environments where UV exposure can be strictly controlled. However, administrative obstacles and criminal exploitation have repeatedly thwarted her efforts to seek foreign specialized care. In addition to a failed attempt via human smugglers during her childhood, Omar's family fell victim to a fraudulent agency that stole $6,000 in donated funds, resulting in formal visa rejections at consulate offices in Erbil.
Avin Hassan Omar's plight underscores the extreme difficulty of managing rare genodermatoses like Xeroderma Pigmentosum in high-UV regions like the Middle East, where inadequate UV-filtered housing, lack of specialized pediatric-to-adult transition clinics, and intense ambient sunlight create severe life-threatening conditions. While oncology centers like Hiwa Hospital manage tumor resections, advanced interventions, such as specialized dermatologic surgery, oral retinoid chemoprevention protocols, and specialized gene-therapy trials, are largely inaccessible in the region. Her situation highlights the critical need for formal humanitarian medical corridors that protect vulnerable rare-disease patients from predatory brokers and facilitate direct access to specialized international research hospitals.
